Group 1 - The board of directors of Jin Jian Rice Industry Co., Ltd. held its 40th meeting on June 27, 2025, to discuss several key proposals [1][2] - The board approved the proposal to amend the company's articles of association and abolish the supervisory board, transferring its powers to the audit committee of the board [1][2] - The proposal to supplement an independent director, Mr. Wu Jinghua, was also approved, pending approval from the upcoming shareholders' meeting [2][3] Group 2 - The board reviewed and approved a proposal for new daily related transactions with a subsidiary of the company's indirect controlling shareholder, with an estimated value not exceeding RMB 7.5 million (excluding tax) [3][4] - The board also approved the adjustment of the transaction entity for certain daily related transactions due to business adjustments by a related party, maintaining the expected transaction amount unchanged [4][5] - A decision was made to hold the company's second extraordinary shareholders' meeting on July 17, 2025 [5] Group 3 - Mr. Wu Jinghua, the independent director candidate, has a Ph.D. in financial management and relevant qualifications, with no conflicts of interest with the company [6]

Core Points - The candidate, Hu Wenyuan, has been nominated as an independent director for Jiangsu Aidi Pharmaceutical Co., Ltd. and confirms his qualifications and independence [1][4] - The candidate possesses over five years of relevant experience in biopharmaceutical research, law, economics, accounting, finance, and management [1] - The candidate meets the legal and regulatory requirements for independent directors as outlined by various Chinese laws and regulations [1] - The candidate declares independence and does not fall under any disqualifying conditions related to family ties, shareholding, or business relationships with the company [1][3] - The candidate has no adverse records in the last 36 months, including no administrative or criminal penalties from the China Securities Regulatory Commission [2][3] - The candidate has not been disqualified from serving as an independent director due to attendance issues in previous roles [3] - The candidate has participated in training and holds relevant certification recognized by the stock exchange [6] - The candidate commits to adhering to laws, regulations, and the rules of the Shanghai Stock Exchange while ensuring sufficient time and effort to fulfill his duties [4]

第一章 总则 第一条 按照建立现代企业制度的要求，进一步完善新世界股份有限公司（以下 简称"公司"）治理结构，促进公司的规范运作，维护公司整体利益，提高公司决 策的科学性和民主性，根据《中华人民共和国公司法》（以下简称"《公司 法》"）、《上市公司独立董事管理办法》、《上市公司治理准则》和《上海新世 界股份有限公司章程》（以下简称"《公司章程》"）的有关规定，制定本制度。 第二条 独立董事是指不在公司担任除董事外的其他职务，并与公司及其主要股 东、实际控制人不存在直接或者间接利害关系，或者其他可能影响其进行独立客观 判断的关系的董事。 第三条 独立董事对公司及全体股东负有忠实与勤勉义务，并应当按照相关法律 法规、中国证券监督管理委员会（以下简称"中国证监会"）规定、上海证券交易 所业务规则和公司章程的规定，认真履行职责，在董事会中发挥参与决策、监督制 衡、专业咨询作用，维护公司整体利益，保护中小股东合法权益。 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单位或者 个人的影响。 独立董事应当重点关注公司的关联交易、对外担保、募集资金使用、社会公众 股股东保护、重大资产重组、重大投融资活动、董事和 ...

Core Viewpoint - The document outlines the governance structure and operational guidelines for Jiangxi Fuxiang Pharmaceutical Co., Ltd, emphasizing the importance of independent directors in protecting the interests of minority shareholders and ensuring the company's compliance with relevant laws and regulations [3][4][5]. Group 1: Governance Structure - The company aims to improve its governance structure by enhancing the board's composition and strengthening the oversight of non-independent directors and management [3]. - Independent directors are defined as those who do not hold any other positions within the company and have no significant relationships that could affect their impartial judgment [4][5]. - At least one-third of the board members must be independent directors, including at least one with accounting expertise [5][6]. Group 2: Responsibilities and Rights of Independent Directors - Independent directors are tasked with participating in board decisions, supervising potential conflicts of interest, and providing professional advice to enhance decision-making [17][18]. - They have the right to independently hire external consultants for audits or investigations and can propose the convening of extraordinary shareholder meetings [11][18]. - Independent directors must disclose their dissenting opinions on board resolutions, ensuring transparency and accountability [20][21]. Group 3: Appointment and Termination - Independent directors can be nominated by the board or shareholders holding at least 1% of the company's shares, with a cumulative voting system for elections [10][11]. - Their term aligns with that of other directors but cannot exceed six consecutive years [14]. - If an independent director resigns, the company must fill the vacancy within 60 days to maintain the required proportion of independent directors [10][14]. Group 4: Compliance and Reporting - Independent directors are required to conduct annual self-assessments of their independence and report their findings to the board [7]. - They must submit an annual performance report to the shareholders' meeting, detailing their attendance and participation in board activities [20][21]. - The company is obligated to provide independent directors with necessary resources and support to fulfill their duties effectively [23][24].

Core Points - The article outlines the establishment of a specialized meeting system for independent directors of Shanghai Jinjiang Online Network Service Co., Ltd to enhance corporate governance and ensure the interests of minority shareholders are considered [1][2][5] Group 1: Meeting Structure and Procedures - The specialized meeting of independent directors is defined as a meeting attended solely by independent directors, focusing on independent discussions and forming opinions from the perspective of the company and minority shareholders [1] - The specialized meeting must be held at least once a year, and can be convened by the meeting organizer or upon the proposal of more than half of the independent directors [2] - A quorum for the meeting requires the presence of more than half of the independent directors, with non-independent directors and relevant personnel allowed to attend but without voting rights [2][5] Group 2: Voting and Decision-Making - Voting at the specialized meeting is conducted on a one-vote-per-person basis, using methods such as on-site voting, written voting, or other legally permitted methods [2] - Independent directors must personally attend the meeting unless special circumstances arise, in which case they can delegate another independent director to attend and vote on their behalf [3] - Certain matters must be discussed and approved by a majority of independent directors before being submitted to the board for consideration, including related party transactions and changes to commitments [3][4] Group 3: Documentation and Reporting - The meeting must be documented accurately, reflecting the opinions of the independent directors, and these records must be signed by the independent directors [4] - Independent directors are required to submit an annual report to the company's annual shareholders' meeting, detailing the work of the specialized meetings [4][5] - The company must provide necessary working conditions and support for the independent directors to fulfill their responsibilities, including access to operational information and resources for conducting investigations [5]

南华期货股份有限公司 独立董事工作制度 第一章 总则 第一条 为进一步完善公司治理结构，切实保护股东的利益，促进公司规范 运作，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公 司独立董事管理办法》（以下简称"《管理办法》"）、《上市公司治理准则》、 上海证券交易所相关业务规则、《香港联合交易所有限公司证券上市规则》（以 下简称"《联交所上市规则》"）等有关法律、法规、规范性文件以及《南华期 货股份有限公司章程》（以下简称"《公司章程》"）的有关规定，特制定本制 度。 第二条 公司独立董事是指不在公司担任除董事外的其他职务，并与公司及 主要股东、实际控制人不存在直接或间接利害关系，或者其他可能影响其进行独 立客观判断的关系的董事。本制度中"独立董事"的含义与《联交所上市规则》 中"独立非执行董事"的含义一致，独立董事须同时符合《联交所上市规则》要 求的独立性。 第三条 独立董事对公司及全体股东负有忠实与勤勉义务，应当按照法律、 行政法规、中国证券监督管理委员会（以下简称"中国证监会"）规定、公司股 票上市地证券监管规则和《公司章程》的规定，认真履行职责，在董事会中发挥 参与决策、监督制衡、专业 ...

上海现代制药股份有限公司 （2025 年 6 月 26 日经 2024 年年度股东大会审议修订） 第一章 总则 独立董事应当按照相关法律法规和《公司章程》的要求，认真履行职责， 在董事会中发挥参与决策、监督制衡、专业咨询作用，维护公司整体利益，保 护中小股东合法权益。 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单位 或者个人的影响。 第二章 独立董事的任职条件和独立性 第四条 独立董事候选人应具备上市公司运作的基本知识，熟悉相关法律法 规和规则，具有 5 年以上法律、经济、财务、管理或者其他履行独立董事职责 所必需的工作经验。 第五条 独立董事候选人任职资格应符合下列法律、行政法规和部门规章的 要求： （一）《中华人民共和国公司法》关于董事任职资格的规定； （二）《中华人民共和国公务员法》关于公务员兼任职务的规定； （三）中国证监会《上市公司独立董事管理办法》的相关规定； 第一条 为进一步完善上海现代制药股份有限公司（以下简称公司）的治理 结构，切实保护中小股东的权益，维护公司利益，促进公司规范运作，根据 《中华人民共和国公司法》《上市公司独立董事管理办法》《上海证券交易所 上市公司自律监管 ...

Core Points - The document outlines the annual report work system for independent directors of Beijing Zhen Shitong Technology Co., Ltd, aiming to enhance the company's operational standards and clarify the responsibilities of independent directors in the annual report process [1][2] Group 1: Responsibilities of Independent Directors - Independent directors are required to ensure that all necessary disclosures in the annual report are truthful, complete, and accurate [3][4] - The chairman of the board is the primary responsible person for the communication mechanism regarding the annual report, while the securities affairs department coordinates the process [1][2] - The management team must cooperate with independent directors to ensure timely, accurate, and complete information is provided [2][3] Group 2: Communication and Oversight - Independent directors must meet with the annual audit registered accountants at least once before the board meeting to discuss issues discovered during the audit process [3][4] - The independent directors are responsible for reviewing the financial reports and ensuring the clarity and completeness of financial information [4][5] - If independent directors have objections regarding the annual report, they must provide written confirmation and can independently hire external audit and consulting firms if necessary [5] Group 3: Confidentiality and Compliance - Independent directors have a confidentiality obligation during the annual report preparation and must prevent insider trading and information leaks [2][3] - They must report any changes in the accounting firm to the regulatory authorities promptly [3][4] - The independent directors are also tasked with reviewing the board meeting procedures and ensuring all necessary documents are in order before the meeting [4][5]

盛美半导体设备（上海）股份有限公司 第二条 独立董事是指不在公司担任除董事外的其他职务，并与公司及其 主要股东、实际控制人不存在直接或者间接利害关系，或者其他可能影响其进行 独立客观判断关系的董事。 （二）符合本制度第六条规定的独立性要求； （三）具备上市公司运作的基本知识，熟悉相关法律法规和规则； 第二章 独立董事的任职资格 第三条 独立董事应当符合下列条件： （一）根据法律、行政法规和其他有关规定，具备担任上市公司董事的资格； 独立董事工作制度 第一章 总 则 第一条 为进一步完善盛美半导体设备（上海）股份有限公司（以下简称 "公司"）的法人治理结构，改善董事会结构，强化对内部董事及经理层的约束 和监督机制，保护中小股东及债权人的利益，促进公司的规范运作，根据《上市 公司独立董事管理办法》《上市公司治理准则》《上海证券交易所科创板上市公 司自律监管指引第 1 号——规范运作》及《盛美半导体设备（上海）股份有限公 司章程》（以下简称"《公司章程》"）等有关规定，并结合公司实际，特制定 本制度。 （四）具有五年以上履行独立董事职责所必需的法律、会计或者经济等工作 经验； （五）具有良好的个人品德，不存在重大失 ...

南京海辰药业股份有限公司 独立董事工作制度 （2025 年【6】月） 第一章 总则 第一条 为完善南京海辰药业股份有限公司(以下称"公司")治理结构，规 范公司运作，更好的维护公司整体利益，保障全体股东特别是中小股东的合法权 益不受损害，根据《中华人民共和国公司法》 （以下称"《公司法》"）、 《上市公司 独立董事管理办法》（以下简称"《管理办法》"）、《上市公司独立董事履职指引》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 （以下简称"《规范运作》"）、 《深圳证券交易所创业板股票上市规则》 （以下简称 "《上市规则》"）《独立董事和审计委员会履职手册》以及《公司章程》（以下称 "《章程》"）的规定，特制定本独立董事工作制度（以下称"本制度"）。 第二条 独立董事系指不在公司担任除董事外的其他职务，并与公司及其 主要股东、实际控制人不存在直接或者间接利害关系，或者其他可能影响其进行 独立客观判断的关系的董事。 第三条 公司目前设独立董事 3 名。如果《章程》规定的董事会成员人数发 生变更，则公司董事会成员中应当有三分之一以上（包括三分之一）是独立董事， 且至少包括一名会计专业 ...